千盛集團控股(08475.HK)與香港全民健康中醫藥生物科技訂立合作備忘錄
格隆匯2月11日丨千盛集團控股(08475.HK)發佈公吿,於2021年2月10日,公司與香港全民健康中醫藥生物科技有限公司(合作伙伴)訂立一份無法律約束力的諒解備忘錄,內容有關與合作伙伴進行潛在合作以開拓潛在合作機會,發揮集團及合作伙伴及其附屬公司的優勢,實現互惠互利。
公司與合作伙伴將就潛在合作的可能方式即刻進行磋商,可能包括但不限於公司(及╱或其附屬公司)與合作伙伴成立合營企業;或公司及╱或公司附屬公司投資合作伙伴;或與合作伙伴集團合作以於集團餐廳提供的食物中加入健康的中國傳統食材。
合作伙伴為於香港註冊成立的有限公司。合作伙伴集團主要於香港及中華人民共和國從事中藥開發及貿易業務。
董事認為訂立諒解備忘錄符合公司及其股東的整體利益,原因是諒解備忘錄項下擬進行的交易如獲落實,預期將增加集團的收入來源。因此,董事會認為訂立諒解備忘錄符合公司及股東的整體利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.